2) Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. 9 Attachment 4 Condensed Consolidated Balance Sheets (Unaudited) March 31, 2021 2020 ASSETS Current assets: Cash and cash equivalents $ 594.5 $ 649.5 Accounts receivable, net 642.2 516.6 Inventories, net 357.0 327.5 Other current assets 122.7 108.5 Total current assets 1,716.4 1,602.1 Property, net 675.5 694.9 Goodwill 1,281.9 1,308.1 Intangible assets, net 973.3 1,008.5 Operating lease assets, net 80.9 80.9 Other non-current assets 181.4 176.0 Total assets $ 4,909.4 $ 4,870.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 18.8 $ 18.6 Accounts payable 529.6 471.7 Current operating lease obligations 24.3 25.1 Accrued expenses and other current liabilities 290.9 285.6 Total current liabilities 863.6 801.0 Non-current liabilities: Long-term debt 1,852.7 1,854.0 Pension and other post-retirement benefits 111.3 115.0 Non-current operating lease obligations 56.8 56.0 Other non-current liabilities 303.0 332.8 Total non-current liabilities 2,323.8 2,357.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 1,707.0 1,697.1 Noncontrolling interest 15.0 14.6 Total equity 1,722.0 1,711.7 Total liabilities and equity $ 4,909.4 $ 4,870.5 10 Attachment 5 Condensed Consolidated Statements of Cash Flows (Unaudited) March 31, 2021 2020 Operating Activities Net income $ 79.7 $ 32.8 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 36.6 19.9 Accelerated depreciation and amortization 0.5 — Share-based compensation expense 2.7 2.1 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (137.6) (56.9) Increase in inventories (35.1) (13.0) Increase in accounts payable 67.3 44.6 Decrease in pension and other post-retirement benefits (7.1) (3.2) Increase in post-acquisition earnout liabilities — 1.0 Decrease in accrued expenses and other assets and liabilities, net (3.4) (19.1) Payment of post-acquisition date earnout liability — (21.0) Net cash provided (used) by operating activities 3.6 (12.8) Investing activities Capital expenditures (16.5) (11.1) Net proceeds from divestiture — 7.1 Net proceeds (used) provided by other assets (2.0) 5.2 Net cash (used) provided by investing activities (18.5) 1.2 Financing activities Purchase of common shares for treasury (4.2) (13.6) Cash dividends paid (19.5) (15.6) Repayment of long-term debt (2.3) (2.0) Payments of withholding tax on share awards (3.1) (1.3) Equity offering proceeds, net of underwriting discount and issuance costs — 496.3 Payment of acquisition date earnout liability — (32.9) Net cash (used) provided by financing activities (29.1) 430.9 Effect of exchange rate changes on cash (11.0) (3.8) (Decrease) increase in cash and cash equivalents (55.0) 415.5 Cash and cash equivalents at beginning of year 649.5 864.7 Cash and cash equivalents at end of period $ 594.5 $ 1,280.2 11 Attachment 6 Business Segment Operations (Unaudited) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (Unaudited) (In millions) Year Ended December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 545.8 $ 641.1 Accounts receivable, net 399.9 440.6 Inventories, net 347.0 372.7 Other current assets 114.9 115.3 Total current assets 1,407.6 1,569.7 Property, net 1,028.9 1,049.2 Goodwill 1,719.3 1,671.9 Intangible assets, net 1,590.8 1,597.6 Operating lease assets, net 65.3 60.4 Other non-current assets 156.6 136.2 Total assets $ 5,968.5 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 9.5 $ 2.2 Accounts payable 432.3 454.4 Current operating lease obligations 16.6 17.0 Accrued expenses and other current liabilities 315.2 395.8 Total current liabilities 773.6 869.4 Non-current liabilities: Long-term debt 2,070.5 2,176.7 Pension and other post-retirement benefits 67.2 67.2 Deferred income taxes 281.6 342.5 Non-current operating lease obligations 43.2 40.9 Other non-current liabilities 394.4 235.5 Total non-current liabilities 2,856.9 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,319.2 2,334.5 Noncontrolling interest 18.8 18.3 Total equity 2,338.0 2,352.8 Total liabilities and equity $ 5,968.5 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Year Ended December 31, 2023 2022 Operating activities Net income $ 76.2 $ 703.4 Adjustments to reconcile net income to net cash provided by operating activities: Gain on sale of business, net of tax expense — (550.1) Depreciation and amortization 186.9 157.6 Accelerated depreciation 1.9 5.5 Amortization of inventory step-up — 34.4 Deferred income tax (benefit) expense (61.3) 0.5 Share-based compensation expense 13.2 13.2 Changes in assets and liabilities, net of the effect of acquisitions: Decrease in accounts receivable 38.6 32.6 Decrease in inventories 24.3 14.0 (Decrease) increase in accounts payable (22.2) 10.7 (Decrease) increase in pension and other post-retirement benefits (15.1) 7.1 Taxes paid on gain on sale of business (104.1) (2.8) Accrued expenses and other assets and liabilities, net 63.2 (27.7) Net cash provided by operating activities 201.6 398.4 Investing activities Capital expenditures (119.4) (105.5) Business acquisitions, net of cash acquired — (1,426.1) Settlement of foreign exchange derivatives — 93.3 Net proceeds from divestiture 7.3 928.2 Proceeds from plant closures 7.6 6.1 Other investing activities 10.3 — Net cash used by investing activities (94.2) (504.0) Financing activities Debt offering proceeds — 1,300.0 Purchase of common shares for treasury — (36.4) Cash dividends paid (90.2) (86.8) Repayment of long-term debt (105.8) (956.8) Payments on withholding tax on share awards (3.4) (4.3) Debt financing costs (2.3) (49.3) Net cash (used) provided by financing activities (201.7) 166.4 Effect of exchange rate changes on cash (1.0) (20.9) (Decrease) increase in cash and cash equivalents (95.3) 39.9 Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of year $ 545.8 $ 641.1 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

SAFETY & HEALTH INDEMNITY Buyer acknowledges that Seller has furnished to Buyer Material Safety Data Sheets as required under applicable laws and regulations, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

Buyer acknowledges that Seller has furnished to Buyer Material Safety Data sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product. 10.

2) Tax adjustments include the net tax impact from non-recurring income tax items and certain adjustments to uncertain tax position reserves and valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (Unaudited) (In millions) Year Ended December 31, 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 544.5 $ 545.8 Accounts receivable, net 399.5 399.9 Inventories, net 346.8 347.0 Other current assets 131.3 114.9 Total current assets 1,422.1 1,407.6 Property, net 955.3 1,028.9 Goodwill 1,659.7 1,719.3 Intangible assets, net 1,450.4 1,590.8 Operating lease assets, net 89.1 65.3 Deferred income tax assets 81.3 92.3 Other non-current assets 153.2 64.3 Total assets $ 5,811.1 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 7.7 $ 9.5 Accounts payable 417.4 432.3 Accrued expenses and other current liabilities 331.0 331.8 Total current liabilities 756.1 773.6 Non-current liabilities: Long-term debt 2,059.3 2,070.5 Deferred income taxes 260.4 281.6 Other non-current liabilities 405.7 504.8 Total non-current liabilities 2,725.4 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,313.8 2,319.2 Noncontrolling interest 15.8 18.8 Total equity 2,329.6 2,338.0 Total liabilities and equity $ 5,811.1 $ 5,968.5 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Year Ended December 31, 2024 2023 Operating activities Net income $ 170.7 $ 76.2 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 179.7 188.8 Increase in environmental insurance receivable (34.0) — Deferred income tax benefit (23.8) (61.3) Share-based compensation expense 15.4 13.2 Changes in assets and liabilities, net of the effect of acquisitions: (Increase) decrease in accounts receivable (15.2) 38.6 (Increase) decrease in inventories (13.7) 24.3 Increase (decrease) in accounts payable 0.3 (22.2) Decrease in pension, retirement benefits and deferred compensation (34.3) (8.7) Taxes paid on gain on sale of business — (104.1) (Decrease) increase in environmental obligations (11.2) 38.9 Accrued expenses and other assets and liabilities, net 22.9 17.9 Net cash provided by operating activities 256.8 201.6 Investing activities Capital expenditures (121.9) (119.4) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 7.6 Other investing activities (2.1) 10.3 Net cash used by investing activities (120.6) (94.2) Financing activities Proceeds from long-term borrowings 650.0 — Payments on long-term borrowings (660.9) (105.8) Cash dividends paid (94.0) (90.2) Payments on withholding tax on share awards (6.4) (3.4) Debt financing costs (9.6) (2.3) Net cash used by financing activities (120.9) (201.7) Effect of exchange rate changes on cash (16.6) (1.0) Decrease in cash and cash equivalents (1.3) (95.3) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of year $ 544.5 $ 545.8 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

2) Tax adjustments include the net tax impact from non-recurring income tax items and certain adjustments to uncertain tax position reserves and valuation allowances. 9 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 505.7 $ 545.8 Accounts receivable, net 465.1 399.9 Inventories, net 377.8 347.0 Other current assets 108.8 114.9 Total current assets 1,457.4 1,407.6 Property, net 973.5 1,028.9 Goodwill 1,716.8 1,719.3 Intangible assets, net 1,542.5 1,590.8 Deferred income taxes 133.1 92.3 Other non-current assets 224.0 129.6 Total assets $ 6,047.3 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 7.8 $ 9.5 Accounts payable 425.9 432.3 Accrued expenses and other current liabilities 460.8 331.8 Total current liabilities 894.5 773.6 Non-current liabilities: Long-term debt 2,059.9 2,070.5 Pension and other post-retirement benefits 63.7 67.2 Deferred income taxes 289.1 281.6 Other non-current liabilities 359.9 437.6 Total non-current liabilities 2,772.6 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,363.0 2,319.2 Noncontrolling interest 17.2 18.8 Total equity 2,380.2 2,338.0 Total liabilities and equity $ 6,047.3 $ 5,968.5 10 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Nine Months Ended September 30, 2024 2023 Operating activities Net income $ 122.2 $ 47.8 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 133.1 142.6 Accelerated depreciation 1.2 1.9 Share-based compensation expense 12.5 9.7 Changes in assets and liabilities: Increase in accounts receivable (65.7) (5.7) (Increase) decrease in inventories (30.2) 16.5 Decrease in accounts payable (5.7) (59.1) Taxes paid on gain on sale of business — (104.1) Accrued expenses and other assets and liabilities, net (33.2) (2.5) Net cash provided by operating activities 134.2 47.1 Investing activities Capital expenditures (80.8) (75.0) Net proceeds from divestiture — 7.3 Proceeds from plant closures 3.4 — Other investing activities (2.1) 2.3 Net cash used by investing activities (79.5) (65.4) Financing activities Proceeds from long-term borrowings 650.0 — Payments on long-term borrowings (659.1) (103.8) Cash dividends paid (70.5) (67.6) Debt financing costs (9.6) (2.3) Other financing activities (4.6) (2.3) Net cash used by financing activities (93.8) (176.0) Effect of exchange rate changes on cash (1.0) (7.2) Decrease in cash and cash equivalents (40.1) (201.5) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 505.7 $ 439.6 11 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

These include new thermoset and thermoplastic composites, which represent the next frontier in lightweighting technology, thermoplastic elastomer adhesives and protective films.  Condensed Consolidated Balance Sheets

More TPE For Beginners Thermoplastic elastomers (TPEs) are used to create durable products that we use everyday.

SAFETY & HEALTH INDEMNITY Buyer acknowledges that Seller has furnished to Buyer Material Safety Data Sheets as required under applicable laws and regulations, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

16 2021 O U TLO O K Synergies ($ millions) Initial Three-Year Estimate Revised Three-Year Estimate 2021 Expected Realization Administrative $ 18 $ 20 $ 15 Sourcing 24 30 15 Operational 18 25 5 Total Synergies $ 60 $ 75 $ 35 CLARIANT INTEGRATION & COST SYNERGIES UPDATE 18 • Integration going extremely well: synergy target increased from $60 million to $75 million • $5 million of synergies in 2020 and expect to realize $35 million in 2021 • Relentless focus on guiding principles of safety first, employee collaboration and exceeding customer expectations • Future revenue synergies are not part of these estimates and represent additional growth over the long term $86 $103 $0.53 $0.70 ORGANIC GROWTH PROJECTIONS – Q1 19 Sales Adjusted Operating Income $991 $1,090 + 10% Adjusted EPS + 20% + 32% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition $308 $360 $1.93 $2.40 ORGANIC GROWTH PROJECTIONS – FULL YEAR 20 Sales Adjusted Operating Income $3,783 $4,100 + 8% Adjusted EPS + 17% + 24% (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (in millions) (in millions) 2020 Pro forma $3,783 $308 Sustainable Solutions 60 11% 24 Healthcare 60 11% 18 Composites 20 10% 10 Growth in Emerging Regions 50 7% 11 Other (GDP growth) 82 5% 11 Sub-total $4,055 7% $382 COVID Response Applications (25) - (11) Outdoor High Performance Applications (15) - (7) Asia Payroll Tax Subsidy (COVID) - - (4) FX Impact 85 - 7 Synergies - - 30 Incentives, Travel, Other Employee Costs - - (37) 2021 Estimated $4,100 8% $360 2021 ORGANIC SALES AND OPERATING INCOME 21 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) COVID Response Applications: facemasks, personal protective equipment Sales Growth Rate Operating Income$ millions (2) CASH FLOW AND LEVERAGE 22 • Asset light business generates significant free cash flow • Cash generation in 2021 partially offset by restructuring activities to capture synergies associated with the Clariant Masterbatch acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition ($ millions) 2020 2021E Adjusted EBITDA 382 510 Working Capital: Source / (Use) 116 (30) Cash Taxes (40) (53) Interest Paid (67) (76) CapEx (62) (75) CapEx for Synergy Capture (2) (20) Restructuring for Synergy Capture (11) (25) Other 22 19 Free Cash Flow 338 250 23 • 8% increase in sales drives 24% increase in adjusted EPS to $2.40 ($2.70 excluding step-up depreciation and amortization) as a result of continued growth in sustainable solutions and synergy capture • Clariant synergy capture ahead of schedule: $35M of savings planned from Clariant Masterbatch acquisition • Adjusted EBITDA of $510M – highest level in company history • Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the end of 2021 2021 PROJECTIONS PEER COMPARISONS 24 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.